2023 -2024 Executive Director, Head of Statistical Programming @
2021 -2022 Sr. Director, Head of Statistical Programming @
2019 -2020 Director, Head of Statistical Programming @
2019 -2019 Director, Statistical Programming @
2015 -2019 Director, Head of Statistical Programming @ IGNYTA, Inc., a wholly owned subsidiary of Roche
2015 -2015 Associate Director @
2009 -2015 Associate Director @ Amylin Pharmaceuticals LLC, a Wholly Owned AstraZeneca Subsidiary
2006 -2009 Sr. Manager @
2005 -2006 Principal Analyst @ Allergan Pharmaceuticals Inc
2000 -2005 Senior Analyst @
Sam Mao Education
Louisiana State University
Master of Science
1999-2000
Sam Mao Skills
Clinical Trials
CRO
Pharmaceutical Industry
Clinical Data Management
CDISC
EDC
GCP
Clinical Development
21 CFR Part 11
Diabetes
Statistical Programming
SAS programming
Statistics
Protocol
CTMS
IND
Drug Discovery
Biostatistics
Computer System Validation
SAS
Regulatory Submissions
Sop
Drug Development
Data Management
Validation
CDISC Standards
Good Clinical Practice (GCP)
Sam Mao Summary
Sam Mao, based in San Diego, CA, US, is currently a Executive Director, Statistical Programming at Bristol Myers Squibb. Sam Mao brings experience from previous roles at Mirati Therapeutics and Eisai US. Sam Mao holds a 1999 - 2000 Master of Science @ Louisiana State University. With a robust skill set that includes Clinical Trials, CRO, Pharmaceutical Industry, Clinical Data Management, CDISC and more. Sam Mao has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Sam Mao?
Find contact details for 700 million professionals.